Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Autoimmune Rheumatic and Non Rheumatic Diseases

The soluble urokinase plasminogen activator receptor (suPAR) is the bioactive form of uPAR, a membrane-bound glycoprotein, and it is primarily expressed on the surface of immunologically active cells. Mirroring local inflammation and immune activation, suPAR has gained interest as a potential progno...

Full description

Bibliographic Details
Main Authors: Mariangela Manfredi, Lieve Van Hoovels, Maurizio Benucci, Riccardo De Luca, Carmela Coccia, Pamela Bernardini, Edda Russo, Amedeo Amedei, Serena Guiducci, Valentina Grossi, Xavier Bossuyt, Carlo Perricone, Maria Infantino
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Journal of Personalized Medicine
Subjects:
Online Access:https://www.mdpi.com/2075-4426/13/4/688
_version_ 1797604778259251200
author Mariangela Manfredi
Lieve Van Hoovels
Maurizio Benucci
Riccardo De Luca
Carmela Coccia
Pamela Bernardini
Edda Russo
Amedeo Amedei
Serena Guiducci
Valentina Grossi
Xavier Bossuyt
Carlo Perricone
Maria Infantino
author_facet Mariangela Manfredi
Lieve Van Hoovels
Maurizio Benucci
Riccardo De Luca
Carmela Coccia
Pamela Bernardini
Edda Russo
Amedeo Amedei
Serena Guiducci
Valentina Grossi
Xavier Bossuyt
Carlo Perricone
Maria Infantino
author_sort Mariangela Manfredi
collection DOAJ
description The soluble urokinase plasminogen activator receptor (suPAR) is the bioactive form of uPAR, a membrane-bound glycoprotein, and it is primarily expressed on the surface of immunologically active cells. Mirroring local inflammation and immune activation, suPAR has gained interest as a potential prognostic biomarker in several inflammatory diseases. Indeed, in many diseases, including cancer, diabetes, cardiovascular diseases, kidney diseases, and inflammatory disorders, higher suPAR concentrations have been associated with disease severity, disease relapse, and mortality. Our review describes and discusses the supporting literature concerning the promising role of suPAR as a biomarker in different autoimmune rheumatic and non-rheumatic diseases.
first_indexed 2024-03-11T04:51:35Z
format Article
id doaj.art-fdc0d76db11845698be2a848e468f2ba
institution Directory Open Access Journal
issn 2075-4426
language English
last_indexed 2024-03-11T04:51:35Z
publishDate 2023-04-01
publisher MDPI AG
record_format Article
series Journal of Personalized Medicine
spelling doaj.art-fdc0d76db11845698be2a848e468f2ba2023-11-17T20:00:45ZengMDPI AGJournal of Personalized Medicine2075-44262023-04-0113468810.3390/jpm13040688Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Autoimmune Rheumatic and Non Rheumatic DiseasesMariangela Manfredi0Lieve Van Hoovels1Maurizio Benucci2Riccardo De Luca3Carmela Coccia4Pamela Bernardini5Edda Russo6Amedeo Amedei7Serena Guiducci8Valentina Grossi9Xavier Bossuyt10Carlo Perricone11Maria Infantino12Immunology and Allergology Laboratory Unit, S. Giovanni di Dio Hospital, 50143 Florence, ItalyDepartment of Microbiology, Immunology and Transplantation, University of Leuven, 3000 Leuven, BelgiumRheumatology Unit, S. Giovanni di Dio Hospital, 50143 Florence, ItalyDepartment of Clinical and Experimental Medicine, University of Florence, 50139 Florence, ItalyDepartment of Clinical and Experimental Medicine, University of Florence, 50139 Florence, ItalyDepartment of Clinical and Experimental Medicine, University of Florence, 50139 Florence, ItalyDepartment of Clinical and Experimental Medicine, University of Florence, 50139 Florence, ItalyDepartment of Clinical and Experimental Medicine, University of Florence, 50139 Florence, ItalyDepartment of Clinical and Experimental Medicine, University of Florence, 50139 Florence, ItalyImmunology and Allergology Laboratory Unit, S. Giovanni di Dio Hospital, 50143 Florence, ItalyDepartment of Microbiology, Immunology and Transplantation, University of Leuven, 3000 Leuven, BelgiumRheumatology Unit, Department of Medicine and Surgery, University of Perugia, 06122 Perugia, ItalyImmunology and Allergology Laboratory Unit, S. Giovanni di Dio Hospital, 50143 Florence, ItalyThe soluble urokinase plasminogen activator receptor (suPAR) is the bioactive form of uPAR, a membrane-bound glycoprotein, and it is primarily expressed on the surface of immunologically active cells. Mirroring local inflammation and immune activation, suPAR has gained interest as a potential prognostic biomarker in several inflammatory diseases. Indeed, in many diseases, including cancer, diabetes, cardiovascular diseases, kidney diseases, and inflammatory disorders, higher suPAR concentrations have been associated with disease severity, disease relapse, and mortality. Our review describes and discusses the supporting literature concerning the promising role of suPAR as a biomarker in different autoimmune rheumatic and non-rheumatic diseases.https://www.mdpi.com/2075-4426/13/4/688suPARrheumatoid arthritisautoimmune diseasesrheumatic diseases
spellingShingle Mariangela Manfredi
Lieve Van Hoovels
Maurizio Benucci
Riccardo De Luca
Carmela Coccia
Pamela Bernardini
Edda Russo
Amedeo Amedei
Serena Guiducci
Valentina Grossi
Xavier Bossuyt
Carlo Perricone
Maria Infantino
Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Autoimmune Rheumatic and Non Rheumatic Diseases
Journal of Personalized Medicine
suPAR
rheumatoid arthritis
autoimmune diseases
rheumatic diseases
title Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Autoimmune Rheumatic and Non Rheumatic Diseases
title_full Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Autoimmune Rheumatic and Non Rheumatic Diseases
title_fullStr Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Autoimmune Rheumatic and Non Rheumatic Diseases
title_full_unstemmed Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Autoimmune Rheumatic and Non Rheumatic Diseases
title_short Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Autoimmune Rheumatic and Non Rheumatic Diseases
title_sort soluble urokinase plasminogen activator receptor supar in autoimmune rheumatic and non rheumatic diseases
topic suPAR
rheumatoid arthritis
autoimmune diseases
rheumatic diseases
url https://www.mdpi.com/2075-4426/13/4/688
work_keys_str_mv AT mariangelamanfredi solubleurokinaseplasminogenactivatorreceptorsuparinautoimmunerheumaticandnonrheumaticdiseases
AT lievevanhoovels solubleurokinaseplasminogenactivatorreceptorsuparinautoimmunerheumaticandnonrheumaticdiseases
AT mauriziobenucci solubleurokinaseplasminogenactivatorreceptorsuparinautoimmunerheumaticandnonrheumaticdiseases
AT riccardodeluca solubleurokinaseplasminogenactivatorreceptorsuparinautoimmunerheumaticandnonrheumaticdiseases
AT carmelacoccia solubleurokinaseplasminogenactivatorreceptorsuparinautoimmunerheumaticandnonrheumaticdiseases
AT pamelabernardini solubleurokinaseplasminogenactivatorreceptorsuparinautoimmunerheumaticandnonrheumaticdiseases
AT eddarusso solubleurokinaseplasminogenactivatorreceptorsuparinautoimmunerheumaticandnonrheumaticdiseases
AT amedeoamedei solubleurokinaseplasminogenactivatorreceptorsuparinautoimmunerheumaticandnonrheumaticdiseases
AT serenaguiducci solubleurokinaseplasminogenactivatorreceptorsuparinautoimmunerheumaticandnonrheumaticdiseases
AT valentinagrossi solubleurokinaseplasminogenactivatorreceptorsuparinautoimmunerheumaticandnonrheumaticdiseases
AT xavierbossuyt solubleurokinaseplasminogenactivatorreceptorsuparinautoimmunerheumaticandnonrheumaticdiseases
AT carloperricone solubleurokinaseplasminogenactivatorreceptorsuparinautoimmunerheumaticandnonrheumaticdiseases
AT mariainfantino solubleurokinaseplasminogenactivatorreceptorsuparinautoimmunerheumaticandnonrheumaticdiseases